Get started
Author

Claudio Marasca

Observed names: Anju George, C Marasca, C. Marasca, Claudio MARASCA, Marasca C
ORCID: 0000-0002-8401-5730
Observed ORCID: 0000-0002-8401-5730
OpenAlex ID: A5091376107
Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review
2018 · G. Fabbrocini, M. Cantelli, et al. · International Journal of Women’s Dermatology · 197
PDF
Hidradenitis Suppurativa: Where We Are and Where We Are Going
2021 · Emanuele Scala, Sara Cacciapuoti, et al. · Cells · 146
PDF
Role of Nutrition and Adherence to the Mediterranean Diet in the Multidisciplinary Approach of Hidradenitis Suppurativa: Evaluation of Nutritional Status and Its Association with Severity of Disease
2018 · Luigi Barrea, Gabriella Fabbrocini, et al. · Nutrients · 117
PDF
Human Microbiome: Composition and Role in Inflammatory Skin Diseases
2018 · Anna Balato, Sara Cacciapuoti, et al. · Archivum Immunologiae et Therapiae Experimentalis · 115
Low glycaemic diet and metformin therapy: a new approach in male subjects with acne resistant to common treatments
2015 · G. Fabbrocini, R. Izzo, et al. · Clinical and Experimental Dermatology · 91
Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience
2023 · Fabrizio Martora, Matteo Megna, et al. · Clinical Cosmetic and Investigational Dermatology · 72
PDF
Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications
2022 · Claudio Marasca, Maria Carmela Annunziata, et al. · Journal of Clinical Medicine · 60
PDF
Paradoxical Hidradenitis Suppurativa during Biologic Therapy, an Emerging Challenge: A Systematic Review
2022 · Angelo Ruggiero, Fabrizio Martora, et al. · Biomedicines · 57
PDF
Effectiveness of Secukinumab in the treatment of moderate–severe hidradenitis suppurativa: results from an Italian multicentric retrospective study in a real‐life setting
2021 · S. Ribero, A. Ramondetta, et al. · Journal of the European Academy of Dermatology and Venereology · 56
Secukinumab and hidradenitis suppurativa: Friends or foes?
2019 · Claudio Marasca, Matteo Megna, et al. · JAAD Case Reports · 55
PDF
Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study
2024 · Fabrizio Martora, Claudio Marasca, et al. · Clinical Cosmetic and Investigational Dermatology · 49
PDF
The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review
2022 · Angelo Ruggiero, Fabrizio Martora, et al. · Clinical Cosmetic and Investigational Dermatology · 48
PDF
Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears
2020 · Matteo Megna, Angelo Ruggiero, et al. · Journal of Dermatological Treatment · 47
Onset of vitiligo in a psoriasis patient on ixekizumab
2021 · Claudio Marasca, Luigi Fornaro, et al. · Dermatologic Therapy · 46
PDF
A case of erythrodermic psoriasis successfully treated with guselkumab
2020 · Matteo Megna, Angelo Ruggiero, et al. · Dermatologic Therapy · 43
PDF
Successful treatment of psoriasis induced by immune checkpoint inhibitors with apremilast
2019 · Davide Fattore, Maria Carmela Annunziata, et al. · European Journal of Cancer · 42
Ixekizumab: An efficacious treatment for both psoriasis and hidradenitis suppurativa
2020 · Matteo Megna, Angelo Ruggiero, et al. · Dermatologic Therapy · 41
PDF
Hidradenitis suppurativa flares following COVID-19 vaccination: A case series
2022 · Fabrizio Martora, Vincenzo Picone, et al. · JAAD Case Reports · 39
Strategies adopted in a southern Italian referral centre to reduce adalimumab discontinuation: comment on ‘Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?’
2022 · Fabrizio Martora, Claudio Marasca, et al. · Clinical and Experimental Dermatology · 38
May COVID-19 outbreaks lead to a worsening of skin chronic inflammatory conditions?
2020 · Claudio Marasca, Angelo Ruggiero, et al. · Medical Hypotheses · 38
PDF
Telemedicine and support groups could be used to improve adherence to treatment and health‐related quality of life in patients affected by inflammatory skin conditions during the COVID‐19 pandemic
2020 · C. Marasca, A. Ruggiero, et al. · Clinical and Experimental Dermatology · 37
PDF
Can COVID‐19 cause atypical forms of pityriasis rosea refractory to conventional therapies?
2021 · Fabrizio Martora, Vincenzo Picone, et al. · Journal of Medical Virology · 36
Management of patients with hidradenitis suppurativa during COVID-19 vaccination: an experience from southern Italy. Comment on: ‘Evaluating the safety and efficacy of COVID-19 vaccination in patients with hidradenitis suppurativa’
2022 · Fabrizio Martora, Claudio Marasca, et al. · Clinical and Experimental Dermatology · 33
A Case of Pemphigus Vulgaris and Hidradenitis Suppurativa: May Systemic Steroids Be Considered in the Standard Management of Hidradenitis Suppurativa?
2022 · Fabrizio Martora, Lorenzo Martora, et al. · Skin Appendage Disorders · 33
PDF
Face the COVID‐19 emergency: measures applied in an Italian Dermatologic Clinic
2020 · C. Marasca, A. Ruggiero, et al. · Journal of the European Academy of Dermatology and Venereology · 33
PDF
Works count: 158
Citation count: 2,593
H-index: 29
I10-index: 67
Year
Topic
Type